retatrutide mastery course
Unit 3 of 12

The GLP-1 Pathway

Appetite suppression, insulin secretion, and gastric emptying

The Appetite Brake

The GLP-1 receptor is the foundation of modern obesity pharmacotherapy. Semaglutide proved that activating this single receptor could produce clinically meaningful weight loss. Retatrutide shares this mechanism but layers two more on top. This unit breaks down exactly how GLP-1 receptor activation suppresses hunger, delays stomach emptying, and fine-tunes insulin release -- the effects that all three drug classes have in common.


GLP-1 Receptor Biology

Receptor location, structure, and downstream signaling pathways.


Appetite Suppression

How GLP-1 signaling in the hypothalamus reduces hunger and food reward.


Gastric Emptying

The vagal nerve mechanism that slows stomach emptying and promotes satiety.


Insulin Secretion

Glucose-dependent insulin release and beta-cell protection.


Shared with Semaglutide

What retatrutide and semaglutide have in common through GLP-1 agonism.